The tumor-enriched subtype was characterized by high expression of keratin cancer oncogenes and low expression of the immune regulatory molecule CD45 and the immune checkpoint protein PD-1, which are regulators of T- and B-cell antigen receptor signaling and T-cell apoptosis, respectively. The gene discussed is PTPRC; the disease is neoplasm.